<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Imprinted genes mediate unique maternal or paternal genetic roles and their function is essential in prenatal development </plain></SENT>
<SENT sid="1" pm="."><plain>The reciprocally imprinted human insulin-like growth factor 2 (IGF2) and H19 genes are expressed during embryonal life, also in the placenta, and are downregulated postnatally </plain></SENT>
<SENT sid="2" pm="."><plain>They reexpress in <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">pediatric tumors</z:e> (e.g. <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>) and in inborn developmental syndromes predisposing to such <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (e.g., <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>H19 (<z:chebi fb="40" ids="33697">RNA</z:chebi> transcripts) and IGF2 are manifested in <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>, immature ovarian <z:hpo ids='HP_0009792'>teratoma</z:hpo> and <z:e sem="disease" ids="C1135868" disease_type="Neoplastic Process" abbrv="">gestational trophoblastic diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We have found that in the placenta and in urothelial <z:mp ids='MP_0002038'>carcinoma</z:mp>, H19 expression reflects the degree of invasiveness </plain></SENT>
<SENT sid="5" pm="."><plain>These genes, displaying a tissue-specific oncofetal pattern of expression, are, therefore, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers </plain></SENT>
</text></document>